Wuhan General Group (OTCMKTS:WUHN) vs. Standex International (NYSE:SXI) Head-To-Head Comparison

Wuhan General Group (OTCMKTS:WUHN) and Standex International (NYSE:SXI) are both industrials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Wuhan General Group and Standex International, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wuhan General Group	0	0	0	0	0.00
Standex International	0	1	4	0	2.80

Standex International has a consensus price target of $246.33, indicating a potential upside of 7.38%. Given Standex International’s stronger consensus rating and higher possible upside, analysts plainly believe Standex International is more favorable than Wuhan General Group.

Earnings and Valuation

This table compares Wuhan General Group and Standex International”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wuhan General Group	N/A	N/A	N/A	N/A	N/A
Standex International	$790.11 million	3.51	$55.76 million	$4.36	52.62

Standex International has higher revenue and earnings than Wuhan General Group.

Risk & Volatility

Wuhan General Group has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Standex International has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.

Profitability

This table compares Wuhan General Group and Standex International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wuhan General Group	N/A	N/A	N/A
Standex International	7.06%	13.92%	6.69%

Insider and Institutional Ownership

90.3% of Standex International shares are owned by institutional investors. 61.1% of Wuhan General Group shares are owned by company insiders. Comparatively, 2.5% of Standex International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Standex International beats Wuhan General Group on 8 of the 10 factors compared between the two stocks.

About Wuhan General Group

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

About Standex International

Standex International Corporation, together with subsidiaries, engages in the manufacture and sale of various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and custom wound transformers and inductors for low and high frequency, current sense technology, advanced planar transformer technology, value added assembly, and mechanical packaging applications under the Standex Electronics, Renco, and Agile Magnetics. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries under the Piazza Rosa, World Client Services, Tenibac-Graphion, GS Engineering, and Innovent brand names. The Scientific segment offers temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets under the American BioTech Supply, Lab Research Products, Corepoint, Cryosafe, CryoGuard, and Scientific brands. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets under the Spincraft brand. The Specialty Solutions segment manufactures and sells refrigerated, heated, and dry merchandizing display cases; and single and double acting telescopic, and piston rod hydraulic cylinders under the Federal and Custom Hoist brands. The company was founded in 1955 and is headquartered in Salem, New Hampshire.